Jiangxi Synergy Pharmaceutical Co., Ltd.

SZSE:300636.SZ

10.41 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q1
Revenue 186.898189.816187.882175.597205.596162.477177.908161.008220.746191.633192.3156.204179.771164.126150.471140.183137.34796.099102.168140.46996.684131.80586.221113.25481.77879.72861.57654.04771.77374.34269.38987.77565.2175.46653.53963.17757.89773.56973.56963.83863.838
Cost of Revenue 135.347130.277127.953119.383130.75597.092130.065112.979141.522120.42131.995116.818124.609114.362103.04197.78598.08461.63364.40395.63161.60294.80755.03577.46362.89854.32542.96538.16753.48149.15745.4253.67439.87747.93934.1739.1232.03545.34445.34437.43237.432
Gross Profit 51.5559.53959.92956.21374.84165.38547.84348.02979.22571.21460.30539.38655.16349.76447.4342.39839.26334.46637.76644.83835.08236.99831.18635.79118.8825.40318.6115.88118.29225.18523.96834.10125.33327.52619.36924.05725.86228.22528.22526.40626.406
Gross Profit Ratio 0.2760.3140.3190.320.3640.4020.2690.2980.3590.3720.3140.2520.3070.3030.3150.3020.2860.3590.370.3190.3630.2810.3620.3160.2310.3190.3020.2940.2550.3390.3450.3890.3880.3650.3620.3810.4470.3840.3840.4140.414
Reseach & Development Expenses 14.14120.24217.02311.88910.29215.6748.94919.31819.2119.60515.60914.20111.49714.6989.6837.8116.82912.5017.6347.5727.59317.0387.8355.7245.7379.5536.47913.6764.97915.7233.3625.956012.7406.51103.8653.853.3313.331
General & Administrative Expenses 9.298-16.43723.159-5.3548.398-22.07625.882-6.9859.06111.73119.667-5.1266.586-9.70212.955-2.3644.527-8.0414.154-2.6553.8-7.6564.074-2.0644.456-1.8126.092-7.4189.427-17.27.568-3.8496.774-15.8355.9317.7265.9347.7187.7186.6346.634
Selling & Marketing Expenses 5.249-7.69411.9436.7355.9268.6945.7246.5365.36.0533.3314.0265.0594.7325.6333.6394.0244.0733.5823.4992.6994.3232.9323.1272.6894.2532.5632.7251.8162.72.4712.2812.0172.4663.7982.5561.5952.7672.7672.1552.155
SG&A 14.547-26.65635.1011.38116.849-13.38131.606-0.44914.36117.85622.998-1.09911.645-4.9718.5881.2748.551-3.9687.7360.8456.499-3.3337.0061.0637.1462.4428.654-4.69411.243-14.510.039-1.5688.791-13.3699.7310.2827.52810.62510.6258.9198.919
Other Expenses 0.81781.721-20.9980.197-7.9210.3271.5033.0680.5030-11.95910.0950.26818.068-7.3676.745-0.34313.08-1.75.38-0.19-0.050.2355.2220.05212.58300.010.034-5.2145.471.1510.4136.9010.9461.0440.4080000
Operating Expenses 29.50544.02331.12628.90935.06331.29124.22328.2734.07440.82626.64823.19623.41127.79620.90415.8315.03721.61313.67113.79813.66822.11615.07712.00912.59824.57815.0714.38811.7366.199.8889.7389.4259.58110.05610.837.8468.1578.1577.9877.987
Operating Income 22.04514.64328.80328.17639.77823.01328.08626.11535.01829.76634.41415.65529.55714.72326.62224.92522.079.17221.21729.98117.8795.07716.5625.5714.473-2.1286.49614.9196.99519.69715.7721.94915.36919.0649.0113.07617.23917.03717.03716.74116.741
Operating Income Ratio 0.1180.0770.1530.160.1930.1420.1580.1620.1590.1550.1790.10.1640.090.1770.1780.1610.0950.2080.2130.1850.0390.1920.2260.055-0.0270.1050.2760.0970.2650.2270.250.2360.2530.1680.2070.2980.2320.2320.2620.262
Total Other Income Expenses Net 03.802-0.4460-0.0677.31600-0.059-3.2094.4040-0.92700000-3.6710-3.05-4.15300-1.04502.9562.710.473-5.2146.5331.151-0.3936.7270.9461.153-0.3692.3272.3270.1830.183
Income Before Tax 22.0459.19228.35728.17648.96523.3428.08626.11534.95926.55734.41415.65529.52414.72326.62224.92522.079.17221.21729.98117.6895.02716.5625.5714.526-2.1286.49614.9297.02814.48321.2423.09915.78125.7919.95614.1217.64719.36419.36416.92516.925
Income Before Tax Ratio 0.1180.0480.1510.160.2380.1440.1580.1620.1580.1390.1790.10.1640.090.1770.1780.1610.0950.2080.2130.1830.0380.1920.2260.055-0.0270.1050.2760.0980.1950.3060.2630.2420.3420.1860.2240.3050.2630.2630.2650.265
Income Tax Expense 1.264-1.6562.1732.1875.402-3.996.4642.1811.8620.3762.566-0.1562.6960.152.6052.5341.932-0.3812.4584.0331.898-1.4011.4833.2370.055-0.442-0.0011.2830.9540.6043.053.092.4023.2991.8721.672.6772.5262.5262.3232.323
Net Income 20.78110.84826.18425.98943.56327.3321.62223.93433.09626.18131.84815.8126.82814.57324.01822.39120.1389.55218.7625.94815.7916.42815.07622.3344.47-1.6866.49713.6466.07413.87818.1920.0113.37922.4928.08412.4514.9716.83816.83814.60214.602
Net Income Ratio 0.1110.0570.1390.1480.2120.1680.1220.1490.150.1370.1660.1010.1490.0890.160.160.1470.0990.1840.1850.1630.0490.1750.1970.055-0.0210.1060.2520.0850.1870.2620.2280.2050.2980.1510.1970.2590.2290.2290.2290.229
EPS 0.050.0260.0620.0620.10.120.0520.0690.0960.0620.140.070.0790.0710.110.0990.0650.0460.0610.130.0820.050.0490.110.015-0.0080.0210.0670.020.0670.0820.0990.0590.140.0340.0780.0650.0730.0730.070.07
EPS Diluted 0.050.0260.0620.0620.10.120.0520.0680.0940.0620.140.070.0790.0650.110.0990.0650.0460.0610.130.0820.050.0490.110.015-0.0080.0210.0670.020.0670.0820.0990.0590.140.0340.0780.0650.0730.0730.070.07
EBITDA 25.033105.91332.37633.27276.03744.38247.15246.47353.78346.27551.25234.05647.87629.20840.60539.36136.4424.1536.10445.65131.4314.41622.76738.28711.5361.3263.5414.946.55620.79614.70723.49416.17528.6549.31313.22718.01529.92117.74817.56317.563
EBITDA Ratio 0.1340.5580.1720.1890.370.2730.2650.2890.2440.2410.2670.2180.2660.1780.270.2810.2650.2510.3530.3250.3250.1090.2640.3380.1410.0170.0570.2760.0910.280.2120.2680.2480.380.1740.2090.3110.4070.2410.2750.275